105 related articles for article (PubMed ID: 8501134)
1. A point mutation in the 5' splice region of intron 7 causes a deletion of exon 7 in adenosine deaminase mRNA.
Kawamoto H; Ito K; Kashii S; Monden S; Fujita M; Norioka M; Sasai Y; Okuma M
J Cell Biochem; 1993 Mar; 51(3):322-5. PubMed ID: 8501134
[TBL] [Abstract][Full Text] [Related]
2. Adenosine deaminase deficiency due to heterozygous abnormality consisting of a deletion of exon 7 and the absence of enzyme mRNA.
Kashii S; Ito K; Monden S; Sasai Y; Tsuchida K; Fujita M; Kawamoto H; Norioka M; Okuma M
J Cell Biochem; 1991 Sep; 47(1):49-53. PubMed ID: 1939366
[TBL] [Abstract][Full Text] [Related]
3. Normal and mutant human adenosine deaminase genes.
Akeson AL; Wiginton DA; Hutton JJ
J Cell Biochem; 1989 Mar; 39(3):217-28. PubMed ID: 2651461
[TBL] [Abstract][Full Text] [Related]
4. Five missense mutations at the adenosine deaminase locus (ADA) detected by altered restriction fragments and their frequency in ADA--patients with severe combined immunodeficiency (ADA-SCID).
Hirschhorn R; Ellenbogen A; Tzall S
Am J Med Genet; 1992 Jan; 42(2):201-7. PubMed ID: 1346349
[TBL] [Abstract][Full Text] [Related]
5. Correct splicing despite mutation of the invariant first nucleotide of a 5' splice site: a possible basis for disparate clinical phenotypes in siblings with adenosine deaminase deficiency.
Arredondo-Vega FX; Santisteban I; Kelly S; Schlossman CM; Umetsu DT; Hershfield MS
Am J Hum Genet; 1994 May; 54(5):820-30. PubMed ID: 8178821
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of adenosine deaminase deficiency.
Markert ML
Immunodeficiency; 1994; 5(2):141-57. PubMed ID: 8032366
[TBL] [Abstract][Full Text] [Related]
7. A novel RNA splicing mutation in Japanese patients with Wilson disease.
Shimizu N; Kawase C; Nakazono H; Hemmi H; Shimatake H; Aoki T
Biochem Biophys Res Commun; 1995 Dec; 217(1):16-20. PubMed ID: 8526905
[TBL] [Abstract][Full Text] [Related]
8. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms.
Lee PL; Gelbart T; West C; Halloran C; Beutler E
Blood Cells Mol Dis; 1998 Jun; 24(2):199-215. PubMed ID: 9642100
[TBL] [Abstract][Full Text] [Related]
9. A de novo G+1-->A mutation at the alpha 2(I) exon 16 splice donor site causes skipping of exon 16 in the cDNA of one allele of an OI type IV proband.
Filie JD; Orrison BM; Wang Q; Lewis MB; Marini JC
Hum Mutat; 1993; 2(5):380-8. PubMed ID: 8257992
[TBL] [Abstract][Full Text] [Related]
10. A single base mutation in the 5' splice site of intron 7 of the lck gene is responsible for the deletion of exon 7 in lck mRNA of the JCaM1 cell line.
Rouer E; Brule F; Benarous R
Oncogene; 1999 Jul; 18(29):4262-8. PubMed ID: 10435639
[TBL] [Abstract][Full Text] [Related]
11. Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype.
Santisteban I; Arredondo-Vega FX; Kelly S; Mary A; Fischer A; Hummell DS; Lawton A; Sorensen RU; Stiehm ER; Uribe L
J Clin Invest; 1993 Nov; 92(5):2291-302. PubMed ID: 8227344
[TBL] [Abstract][Full Text] [Related]
12. Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase missense mutation (Arg253Pro).
Hirschhorn R; Yang DR; Insel RA; Ballow M
Cell Immunol; 1993 Dec; 152(2):383-93. PubMed ID: 8258146
[TBL] [Abstract][Full Text] [Related]
13. Identification of a deletion in the adenosine deaminase gene in a child with severe combined immunodeficiency.
Markert ML; Hershfield MS; Wiginton DA; States JC; Ward FE; Bigner SH; Buckley RH; Kaufman RE; Hutton JJ
J Immunol; 1987 May; 138(10):3203-6. PubMed ID: 3571974
[TBL] [Abstract][Full Text] [Related]
14. Essential nucleotides direct neuron-specific splicing of gamma 2 pre-mRNA.
Zhang L; Ashiya M; Sherman TG; Grabowski PJ
RNA; 1996 Jul; 2(7):682-98. PubMed ID: 8756411
[TBL] [Abstract][Full Text] [Related]
15. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
[TBL] [Abstract][Full Text] [Related]
16. Myoadenylate deaminase deficiency caused by alternative splicing due to a novel intronic mutation in the AMPD1 gene.
Isackson PJ; Bujnicki H; Harding CO; Vladutiu GD
Mol Genet Metab; 2005; 86(1-2):250-6. PubMed ID: 16040263
[TBL] [Abstract][Full Text] [Related]
17. Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency.
Bonthron DT; Markham AF; Ginsburg D; Orkin SH
J Clin Invest; 1985 Aug; 76(2):894-7. PubMed ID: 3839802
[TBL] [Abstract][Full Text] [Related]
18. Somatic mosaicism for a newly identified splice-site mutation in a patient with adenosine deaminase-deficient immunodeficiency and spontaneous clinical recovery.
Hirschhorn R; Yang DR; Israni A; Huie ML; Ownby DR
Am J Hum Genet; 1994 Jul; 55(1):59-68. PubMed ID: 8023852
[TBL] [Abstract][Full Text] [Related]
19. Retarded and aberrant splicings caused by single exon mutation in a phosphoglycerate kinase variant.
Ookawara T; Davé V; Willems P; Martin JJ; de Barsy T; Matthys E; Yoshida A
Arch Biochem Biophys; 1996 Mar; 327(1):35-40. PubMed ID: 8615693
[TBL] [Abstract][Full Text] [Related]
20. Novel splice variants of human ADAR2 mRNA: skipping of the exon encoding the dsRNA-binding domains, and multiple C-terminal splice sites.
Kawahara Y; Ito K; Ito M; Tsuji S; Kwak S
Gene; 2005 Dec; 363():193-201. PubMed ID: 16297572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
